17 August 2017
Visiongain’s new report Global Syringes Market Forecast 2017-2027: Revenue Prospects by Syringe Type (Reusable, Disposable), Material (Glass, Plastic), Product Type (Insulin, Tuberculin, Allergy, Other), End User (Hospitals, Homecare, Other) and Geography indicates that the Global Syringes market will see over $15bn in revenue in 2017.
The lead analyst of the report said:
“The increase in the demand for disposable syringes such as prefilled and safety syringes compared to others is extraordinarily high in North America in the upcoming years owing to the increasing prevalence rate of needle-stick injuries, increasing government funding for the use of these syringes in hospital settings, and an aging population with high incidence of chronic diseases.
Growing research on automatic safety syringes is driving the sales of safety syringes since the increasing demand for use in developed nations and more preference to automatic retractable syringes over manual syringes as they are safer and easier to handle.
Furthermore, increasing demand for point-of-care treatment is driving the market for disposable syringes market coupled with patient preference for self-administration and the increasing geriatric population. Moreover, the higher level of use of biological drugs (mostly as injectable drugs) is providing a small, yet additional push for market growth over the forecast period”
The 250-page report contains 218 tables, charts and graphs that add visual analysis in order to explain developing trends within the Global Syringes market. Visiongain provides revenue forecasts for the period 2017-2027 for the leading Global Syringes submarkets, segmented by syringe type, including forecasts for reusable/sterilisable and disposable syringes. The market is also segmented by material, with forecasts for glass and plastic syringes from 2017-2027. In addition, the market is segmented by product type, with forecasts for insulin syringes, tuberculin syringes, syringes used to deliver allergy medication and others. Finally, the global syringes market is segmented by end-user, with forecasts for hospitals, homecare and other settings.
The 250-page report offers market forecasts and analysis for 21 key national markets. In addition, the report contains a dedicated leading companies’ chapter covering 10 companies leading the Global Syringes field in detail.
The Global Syringes Market Forecast 2017-2027: Revenue Prospects by Syringe Type (Reusable, Disposable), Material (Glass, Plastic), Product Type (Insulin, Tuberculin, Allergy, Other), End User (Hospitals, Homecare, Other) and Geography report will be of value to anyone who wants to better understand the Global Syringes market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the global syringes industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.
23 September 2020
. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.
16 September 2020
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.
14 September 2020
The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.